Abstract

Gene networks have been broadly used to predict gene functions based on guilt by association (GBA) principle. Thus, in order to better understand the molecular mechanisms of esophageal squamous cell carcinoma (ESCC), our study was designed to use a network-based GBA method to identify the optimal gene functions for ESCC. To identify genomic bio-signatures for ESCC, microarray data of GSE20347 were first downloaded from a public functional genomics data repository of Gene Expression Omnibus database. Then, differentially expressed genes (DEGs) between ESCC patients and controls were identified using the LIMMA method. Afterwards, construction of differential co-expression network (DCN) was performed relying on DEGs, followed by gene ontology (GO) enrichment analysis based on a known confirmed database and DEGs. Eventually, the optimal gene functions were predicted using GBA algorithm based on the area under the curve (AUC) for each GO term. Overall, 43 DEGs and 67 GO terms were gained for subsequent analysis. GBA predictions demonstrated that 13 GO functions with AUC>0.7 had a good classification ability. Significantly, 6 out of 13 GO terms yielded AUC>0.8, which were determined as the optimal gene functions. Interestingly, there were two GO categories with AUC>0.9, which included cell cycle checkpoint (AUC=0.91648), and mitotic sister chromatid segregation (AUC=0.91597). Our findings highlight the clinical implications of cell cycle checkpoint and mitotic sister chromatid segregation in ESCC progression and provide the molecular foundation for developing therapeutic targets.

Highlights

  • Esophageal squamous cell carcinoma (ESCC), one of the most lethal malignancies in humans, results in more than 400,000 deaths per year

  • A total of 43 genes were identified as differentially expressed genes (DEGs) at FDRo0.001 and |logFC|42

  • The guilt by association (GBA) principle is the foundation for most gene function prediction approaches, which typically employs relational data to predict gene membership in categories of gene function [29]

Read more

Summary

Introduction

Esophageal squamous cell carcinoma (ESCC), one of the most lethal malignancies in humans, results in more than 400,000 deaths per year. Patients with ESCC are usually diagnosed at an advanced stage, and the 5-year survival rate is reported to be less than 15% [1]. ESCC development is influenced by multiple factors, involving changes of gene expression as well as physiological structure [2]. With the rapid development of molecular biology, many scholars have conducted in-depth analysis on the etio-pathogenesis of ESCC from gene level, and a large number of significant genes has been detected. Up-regulation of epidermal growth factor receptor and cyclin D1, and expression of p53 mis-sense mutations have been associated with ESCC progression [3]. Recent high-throughput cancer genome sequencing revealed several gene mutations (ADAM29, MLL2, ASH1L, SETD1B, MLL3, EP300, CREBBP, and FAM135B) in ESCC [4]. Further studies are imperative to understand the underlying molecular basis of ESCC

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call